246 related articles for article (PubMed ID: 28522956)
21. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases.
Pu D; Zhang Z; Feng B
Front Pharmacol; 2022; 13():906419. PubMed ID: 35734396
[TBL] [Abstract][Full Text] [Related]
22. Gut dysbiosis and paediatric Crohn's disease.
Brusaferro A; Cavalli E; Farinelli E; Cozzali R; Principi N; Esposito S
J Infect; 2019 Jan; 78(1):1-7. PubMed ID: 30336176
[TBL] [Abstract][Full Text] [Related]
23. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
24. Fecal microbiota transplantation in refractory ulcerative colitis - a case report.
Moutinho BD; Baima JP; Rigo FF; Saad-Hossne R; Rodrigues J; Romeiro FG; Sassaki LY
J Int Med Res; 2019 Feb; 47(2):1072-1079. PubMed ID: 30632438
[TBL] [Abstract][Full Text] [Related]
25. [Insights into the Pathogenesis of Inflammatory Bowel Diseases: Genetics and Microbiota].
Marchukov D; Misselwitz B
Ther Umsch; 2019 Jan; 75(5):273-279. PubMed ID: 30700240
[TBL] [Abstract][Full Text] [Related]
26. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
Fritsch J; Abreu MT
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
[TBL] [Abstract][Full Text] [Related]
27. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.
Schaubeck M; Clavel T; Calasan J; Lagkouvardos I; Haange SB; Jehmlich N; Basic M; Dupont A; Hornef M; von Bergen M; Bleich A; Haller D
Gut; 2016 Feb; 65(2):225-37. PubMed ID: 25887379
[TBL] [Abstract][Full Text] [Related]
28. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
Serban DE
Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
[TBL] [Abstract][Full Text] [Related]
29. Differences in epidemiological features between ulcerative colitis and Crohn's disease: The early life-programmed versus late dysbiosis hypothesis.
Beaugerie L; Langholz E; Nyboe-Andersen N; Pigneur B; Sokol H;
Med Hypotheses; 2018 Jun; 115():19-21. PubMed ID: 29685190
[TBL] [Abstract][Full Text] [Related]
30. Fecal microbiota transplantation: great potential with many challenges.
Kellermayer R
Transl Gastroenterol Hepatol; 2019; 4():40. PubMed ID: 31231707
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
32. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
[TBL] [Abstract][Full Text] [Related]
33. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn's disease.
Li P; Zhang T; Xiao Y; Tian L; Cui B; Ji G; Liu YY; Zhang F
Appl Microbiol Biotechnol; 2019 Jan; 103(1):349-360. PubMed ID: 30357440
[TBL] [Abstract][Full Text] [Related]
34. The Crohn's disease polymorphism,
Lavoie S; Conway KL; Lassen KG; Jijon HB; Pan H; Chun E; Michaud M; Lang JK; Gallini Comeau CA; Dreyfuss JM; Glickman JN; Vlamakis H; Ananthakrishnan A; Kostic A; Garrett WS; Xavier RJ
Elife; 2019 Jan; 8():. PubMed ID: 30666959
[TBL] [Abstract][Full Text] [Related]
35. Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies.
Basso PJ; Câmara NOS; Sales-Campos H
Front Pharmacol; 2018; 9():1571. PubMed ID: 30687107
[TBL] [Abstract][Full Text] [Related]
36. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
37. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
38. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
[TBL] [Abstract][Full Text] [Related]
39. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
40. Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Lopez J; Grinspan A
Gastroenterol Hepatol (N Y); 2016 Jun; 12(6):374-9. PubMed ID: 27493597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
